Boldo para vesícula
Peumus boldus — 8 estudios científicos revisados
Preliminary¿Sirve Boldo para vesícula?
La investigación científica ha explorado el potencial de Boldo (Peumus boldus) en relación con vesícula. Se han identificado 8 estudios relevantes que examinan esta relación.
Compuestos activos involucrados: boldina, cineol, ascaridol, flavonoides, Alcaloides, Saponinas, Terpeno, Terpenos, Conocido, Saponina, Compuestos fenólicos
Evidencia Científica
Los siguientes estudios han investigado la relación entre Boldo y vesícula:
From the Amazon to modern pharmacology: medicinal plants as metabolic and cardiovascular modulators in cardiodiabesity.
This study presents a literature review on the therapeutic potential of five medicinal plants-Astrocaryum aculeatum (tucumã), Plectranthus barbatus (Brazilian boldo), Myrciaria dubia (camu-camu), Ilex paraguariensis (yerba mate), and Passiflora incarnata (passionflower) - in the management of cardiodiabesity, a complex condition that interconnects type 2 diabetes mellitus and cardiovascular diseases. The methodology involved systematic searches in PubMed, Scopus, and Web of Science platforms, using descriptors related to medicinal plants, clinical conditions associated with cardiodiabesity, an
PubMed: 40781374Boldine: a narrative review of the bioactive compound with versatile biological and pharmacological potential.
OBJECTIVE: Boldine is a plant-derived bioactive compound that has a beneficial impact on human health. Boldine is an aporphine alkaloid mainly obtained from the leaves and bark of the Chilean Boldo tree (Peumus boldus, Family: Monimiaceae). There are plenty of preclinical evidence supports that boldine exerts its beneficial effects against various diseases. Lumiskin™, a patented and marketed formulation by Revitol Skincare for skin brightening, contains Dicetyl boldine, a boldine derivative. CONTENT: All the available information on the Chilean boldo tree (P.
PubMed: 38234264Herbal and dietary supplement induced liver injury: Highlights from the recent literature.
Herbal-induced liver injury (HILI) is an important and increasingly concerning cause of liver toxicity, and this study presents recent updates to the literature. An extensive literature review was conducted encompassing September 2019 through March 2021. Studies with clinically significant findings were analyzed and included in this review. We emphasized those studies that provided a causality assessment methodology, such as Roussel Uclaf Causality Assessment Method scores. Our review includes reports of individual herbals, including Garcinia cambogia, green tea extract, kratom as well as clas
PubMed: 34630872Biochemical characterization of Peumus boldus fruits: Insights of its antioxidant properties through a theoretical approach.
Peumus boldus is an endemic tree species from Chile whose leaves have been the focus of study for decades given that their infusions are reported to relieve rheumatic symptoms, headache, dyspepsia, urinary tract inflammation, and symptoms of other illnesses. These health properties have been studied mainly using leaves and bark, then it is relevant to know more about these properties in different parts of the plant. Considering the importance of P. boldus fruits in the diet of some rural populations, we analyzed their properties to explore its impact on the Chilean population health. Liquid ch
PubMed: 34500293Vascular implications of Dasineura sp. galls' establishment on Peumus boldus stems.
Some chewing larvae are capable of inducing galls in the host vascular cylinder, e.g. Dasineura sp. (Cecidomyiidae) on Peumus boldus stems. Due to the medicinal and economic importance of P. boldus, the anatomical and functional implications of establishment of Dasineura sp.
PubMed: 37432095Seguridad y Precauciones
El uso de Peumus boldus debe abordarse con extrema precaución debido a su compleja composición de alcaloides y terpenos. En el caso de mujeres embarazadas y en periodo de lactancia, su uso está estrictamente desaconsejado. No existen estudios clínicos suficientes que garanticen la ausencia de efectos teratogénicos o riesgos para el desarrollo fetal; además, la boldina y otros compuestos pueden atravesar la barrera placentaria o excretarse en la leche materna, con potenciales efectos sobre el lactante. En niños menores de 12 años, el uso de boldo no se recomienda debido a la inmadurez de sus sistemas enzimáticos hepáticos y renales, lo que incrementa el riesgo de toxicidad por la acumulación de metabolitos. Respecto a las interacciones farmacológicas, el boldo puede alterar significativamente la farmacocinética de medicamentos metabolizados por el sistema del citocromo P450 (CYP450). Se ha observado que el boldo puede inducir el sistema CYP450 y la bomba de eflujo P-gp, lo que podría disminuir la biodisponibilidad de fármacos críticos como el tacrolimus (un inmunosupresor vital para trasplantados) [PMID 39757635].
Perfil completo: Ver todos los usos y evidencia de Boldo →